Published in JAMA on March 17, 2004
Blood Pressure-Improving Control Among Alaska Native People" (BP-ICAN) (CHAR2) | NCT03872856
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 2.96
Blood pressure and mortality among hemodialysis patients. Hypertension (2010) 1.74
Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol (2009) 1.71
The cloud paradigm applied to e-Health. BMC Med Inform Decis Mak (2013) 1.62
Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study. J Am Coll Cardiol (2015) 1.62
Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens (2009) 1.57
Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension (2008) 1.54
Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study. J Hypertens (2014) 1.53
Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med (2005) 1.51
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2007) 1.49
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2006) 1.42
Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework. Contemp Clin Trials (2007) 1.31
Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol (2009) 1.26
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens (2014) 1.25
Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study. Hypertens Res (2012) 1.22
Principles and techniques of blood pressure measurement. Cardiol Clin (2010) 1.20
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Self monitoring of blood pressure at home. BMJ (2004) 1.14
Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol (2007) 1.13
Endothelial-dependent flow-mediated dilation in African Americans with masked-hypertension. Am J Hypertens (2011) 1.11
Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks. J Hum Hypertens (2013) 1.10
Experiences of patients and professionals participating in the HITS home blood pressure telemonitoring trial: a qualitative study. BMJ Open (2013) 1.08
Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines. CMAJ (2008) 1.04
Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study. J Hypertens (2009) 1.04
Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol (2011) 1.03
Patient self-management support: novel strategies in hypertension and heart disease. Cardiol Clin (2010) 1.00
Management of hypertension in the elderly. Nat Rev Cardiol (2012) 0.98
Self-measurement of blood pressure at home in the management of hypertension. Clin Med Res (2005) 0.97
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response. J Transl Med (2012) 0.97
Mail education is as effective as in-class education in hypertensive Korean patients. J Clin Hypertens (Greenwich) (2008) 0.96
Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep (2011) 0.95
Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I). Curr Control Trials Cardiovasc Med (2005) 0.94
Masked Uncontrolled Hypertension in CKD. J Am Soc Nephrol (2015) 0.94
Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis (2012) 0.94
Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Semin Nephrol (2007) 0.93
Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag (2005) 0.92
Practical advice for home blood pressure measurement. Can J Cardiol (2007) 0.92
The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO): moving from baseline characteristics to research perspectives. Hypertens Res (2012) 0.92
Clinical implications of ambulatory and home blood pressure monitoring. Korean Circ J (2010) 0.91
Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension (2012) 0.91
Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol (2006) 0.90
Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. Can J Cardiol (2010) 0.90
Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis. Blood Press Monit (2011) 0.87
The influence of self-owned home blood pressure monitoring (HBPM) on primary care patients with hypertension: a qualitative study. BMC Fam Pract (2011) 0.86
Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris. Med Sci Monit (2013) 0.85
Masked hypertension: evidence of the need to treat. Curr Hypertens Rep (2010) 0.85
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension. Vasc Health Risk Manag (2007) 0.84
I Brazilian position paper on prehypertension, white coat hypertension and masked hypertension: diagnosis and management. Arq Bras Cardiol (2014) 0.84
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension (2016) 0.84
Highlights and summary of the 2006 Canadian Hypertension Education Program recommendations. Can J Cardiol (2006) 0.83
A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours. Vasc Health Risk Manag (2006) 0.81
Cost-effectiveness of secondary screening modalities for hypertension. Blood Press Monit (2013) 0.81
What is the optimal interval between successive home blood pressure readings using an automated oscillometric device? J Hypertens (2009) 0.81
Maternal clinic and home blood pressure measurements during pregnancy and infant birth weight: the BOSHI study. Hypertens Res (2015) 0.81
Morning blood pressure at home predicts erythropoietin-induced hypertension in patients with chronic renal diseases. Clin Exp Nephrol (2007) 0.80
The applicability of home blood pressure measurement in clinical practice: a review of literature. Vasc Health Risk Manag (2007) 0.80
Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. Clin J Am Soc Nephrol (2016) 0.80
Masked hypertension: a common but insidious presentation of hypertension. Can J Cardiol (2006) 0.80
Out-of-office blood pressure: from measurement to control. Integr Blood Press Control (2012) 0.79
Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure. Clin Exp Nephrol (2009) 0.79
The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II). Curr Control Trials Cardiovasc Med (2005) 0.78
Challenges and scientific considerations in hypertension management reflected in the 2012 recommendations of the Canadian Hypertension Education Program. Open Med (2012) 0.78
Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients. Hypertens Res (2015) 0.78
Frequency and related factors of masked hypertension at a worksite in Korea. J Prev Med Public Health (2011) 0.78
Ambulatory blood pressure monitoring in the elderly. Int J Hypertens (2011) 0.77
Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study. Hypertens Res (2016) 0.77
IMPPACT: Investigation of Medical Professionals and Patients Achieving Control Together. Can J Cardiol (2008) 0.77
The impact of a cardiovascular health awareness program (CHAP) on reducing blood pressure: a prospective cohort study. BMC Public Health (2013) 0.77
Does a colour-coded blood pressure diary improve blood pressure control for patients in general practice: the CoCo trial. Trials (2010) 0.77
The complex relationship between CKD and ambulatory blood pressure patterns. Adv Chronic Kidney Dis (2015) 0.77
Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes. Heart Vessels (2011) 0.76
Evaluation of dosing time-related anti-hypertensive efficacy of valsartan in patients with type 2 diabetes. Clin Exp Hypertens (2010) 0.76
Telemedicine home blood pressure measurements and progression of albuminuria in elderly people with diabetes. Hypertension (2008) 0.76
Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus. J Diabetes Investig (2010) 0.76
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens (2017) 0.75
Diagnosis of true uncontrolled hypertension using both home and ambulatory blood pressure monitoring. J Hum Hypertens (2013) 0.75
Effects of irbesartan on 24-h blood pressure changes and urinary albumin levels in Japanese outpatients. Exp Ther Med (2010) 0.75
Should we screen for masked hypertension in patient with vascular disease? Vasc Health Risk Manag (2010) 0.75
Uncontrolled hypertension in older patients: markers and associated factors to masked and white-coat effect. J Geriatr Cardiol (2016) 0.75
Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study. J Clin Hypertens (Greenwich) (2014) 0.75
Determinants of the Morning-Evening Home Blood Pressure Difference in Treated Hypertensives: The HIBA-Home Study. Int J Hypertens (2014) 0.75
Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol. BMJ Open (2015) 0.75
BPcontrol. A Mobile App to Monitor Hypertensive Patients. Appl Clin Inform (2016) 0.75
Home blood pressure and cardiovascular risk in treated hypertensive patients: the prognostic value of the first and second measurements and the difference between them in the HONEST study. Hypertens Res (2016) 0.75
Home blood pressure monitoring as an intervention to control hypertension: comment on "Home blood pressure management and improved blood pressure control". Arch Intern Med (2011) 0.75
Efficacy of Blood Pressure reduction of Losartan in selected Thai populations using Home Blood Pressure Monitoring and Office Blood Pressure measurements. ASEAN Heart J (2015) 0.75
Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data. BMJ Open (2014) 0.75
Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure. Cardiol Ther (2015) 0.75
Clinical significance of home blood pressure and its possible practical application. Clin Exp Nephrol (2013) 0.75
Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med (2017) 0.75
Masked Hypertension. Curr Hypertens Rep (2017) 0.75
Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients. Clin Exp Nephrol (2012) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med (2006) 12.90
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med (2011) 7.21
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol (2008) 4.12
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum (2005) 3.44
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30
Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J (2008) 2.51
Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest (2009) 2.40
Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke (2005) 2.38
Masked hypertension: a systematic review. J Hypertens (2008) 2.10
The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens (2002) 2.03
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med (2007) 2.03
Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography. J Hypertens (2011) 1.99
Integrating clinical research with the Healthcare Enterprise: from the RE-USE project to the EHR4CR platform. J Biomed Inform (2011) 1.81
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab (2005) 1.75
EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens (2008) 1.69
Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol (2004) 1.69
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT study. J Nucl Med (2011) 1.62
Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology (2004) 1.62
Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant (2004) 1.61
Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol (2004) 1.61
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J Hypertens (2012) 1.59
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J (2008) 1.54
Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens (2006) 1.51
Pulse pressure monitoring of open antihypertensive therapy. Am J Hypertens (2004) 1.50
Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J Thorac Cardiovasc Surg (2004) 1.49
Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA (2012) 1.48
Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ (2005) 1.44
Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis (2010) 1.44
European Society of Hypertension scientific newsletter: hypertension and aortic diseases. J Hypertens (2012) 1.44
A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens (2005) 1.42
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum? J Hypertens (2012) 1.41
The EVAPIL scale, a new tool to assess tolerance of oral contraceptives. Contraception (2009) 1.39
Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis. High Blood Press Cardiovasc Prev (2013) 1.39
Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol (2007) 1.36
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation (2004) 1.36
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum (2011) 1.35
Aldosterone synthase inhibition in humans. Nephrol Dial Transplant (2012) 1.30
Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol (2011) 1.29
Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. AJR Am J Roentgenol (2006) 1.28
The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest (2005) 1.22
The readability of information and consent forms in clinical research in France. PLoS One (2010) 1.19
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum (2009) 1.18
Socioeconomic inequalities in hypertension prevalence and care: the IHPAF Study. Hypertension (2002) 1.18
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study. Rheumatology (Oxford) (2009) 1.18
Influenza-like illness responsible for severe exacerbations in asthmatic children during H1N1 pandemic: a survey before vaccination. J Asthma (2011) 1.17
Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J (2010) 1.17
Is It possible to recognize pulmonary infarction on multisection CT images? Radiology (2007) 1.15
Coccygectomy for instability of the coccyx. Int Orthop (2004) 1.14
Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens (2003) 1.14
Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism. Hypertension (2010) 1.14
Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens (Greenwich) (2007) 1.12
Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med (2009) 1.12
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme. Eur J Heart Fail (2009) 1.11
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats. J Hypertens (2005) 1.10
Safety of endovascular treatment of carotid artery stenosis compared with surgical treatment: a meta-analysis. J Vasc Surg (2008) 1.10
Diagnosis of tetanus immunization status: multicenter assessment of a rapid biological test. Clin Diagn Lab Immunol (2005) 1.09
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology (2010) 1.09
Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens (2005) 1.08
Diabetes as a marker of pheochromocytoma in hypertensive patients. J Hypertens (2003) 1.08
Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration. Stroke (2013) 1.07
Reliability, validity, and health issues arising from questionnaires used to measure Psychosocial and Organizational Work Factors (POWFs) among hospital nurses: a critical review. J Nurs Meas (2008) 1.06
Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators. J Clin Endocrinol Metab (2012) 1.06
Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study. BMC Nephrol (2012) 1.04
Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum (2009) 1.03
Masked hypertension in obstructive sleep apnea syndrome. J Hypertens (2008) 1.01
Outcomes in older patients after surgical treatment for hip fracture: a new approach to characterise the link between readmissions and the surgical stay. Age Ageing (2009) 1.00
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era. Ann Rheum Dis (2012) 1.00
Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer. Drugs Aging (2007) 0.98
Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting. Stroke (2009) 0.98
Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome? J Natl Cancer Inst (2007) 0.96
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am J Hypertens (2004) 0.96
Self-monitoring of blood pressure should be used in clinical trials. Blood Press Monit (2002) 0.95
Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry. Am Heart J (2005) 0.95
Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size. J Hypertens (2002) 0.94
Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Int J Cancer (2011) 0.93
Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study). J Hypertens (2002) 0.93
Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Rheumatology (Oxford) (2010) 0.92
Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol (2005) 0.92
Adjustment for reporting bias in network meta-analysis of antidepressant trials. BMC Med Res Methodol (2012) 0.92
The treatment of chronic coccydynia with intrarectal manipulation: a randomized controlled study. Spine (Phila Pa 1976) (2006) 0.91
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord (2012) 0.91
Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. Chest (2011) 0.90
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie). J Rheumatol (2009) 0.90
Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension (2003) 0.89